Ian Quigley says their evaluation reveals agent behaviors including early abandonment, choices inconsistent with stated hypotheses, repeated testing of the same molecules, and varying exploration-exploitation decisions.

“And so there we see all kinds of interesting behaviors like agents that give up early, uh, want to buy molecules that don't agree with the rest of their hypotheses, ones that keep retesting the same molecules over and over despite having a limited budget, and also when it's good to explore versus exploit.”